- $126.68m
- $381.06m
- $56.94m
- 56
- 95
- 31
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 13.4 | 37.7 | 43 | 14.9 | 45.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.35 | 1.3 | 16.4 | 2.2 | 2.22 |
Prepaid Expenses | |||||
Net Goodwill | |||||
Long Term Investments | |||||
Total Assets | 538 | 484 | 569 | 521 | 470 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 372 | 325 | 365 | 340 | 308 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 167 | 159 | 204 | 180 | 162 |
Total Liabilities & Shareholders' Equity | 538 | 484 | 569 | 521 | 470 |
Total Common Shares Outstanding |